» Articles » PMID: 34335962

Molecular Imaging of Fibroblast Activation Protein After Myocardial Infarction Using the Novel Radiotracer [Ga]MHLL1

Overview
Journal Theranostics
Date 2021 Aug 2
PMID 34335962
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Myocardial infarction (MI) evokes an organized remodeling process characterized by the activation and transdifferentiation of quiescent cardiac fibroblasts to generate a stable collagen rich scar. Early fibroblast activation may be amenable to targeted therapy, but is challenging to identify . We aimed to non-invasively image active fibrosis by targeting the fibroblast activation protein (FAP) expressed by activated (myo)fibroblasts, using a novel positron emission tomography (PET) radioligand [Ga]MHLL1 after acute MI. One-step chemical synthesis and manual as well as module-based radiolabeling yielded [Ga]MHLL1. Binding characteristics were evaluated in murine and human FAP-transfected cells, and stability tested in human serum. Biodistribution in healthy animals was interrogated by dynamic PET imaging, and metabolites were measured in blood and urine. The temporal pattern of FAP expression was determined by serial PET imaging at 7 d and 21 d after coronary artery ligation in mice as percent injected dose per gram (%ID/g). PET measurements were validated by autoradiography and immunostaining for FAP and inflammatory macrophages. [Ga]MHLL1 displayed specific uptake in murine and human FAP-positive cells (p = 0.0208). In healthy mice the tracer exhibited favorable imaging characteristics, with low blood pool retention and dominantly renal clearance. At 7 d after coronary artery ligation, [Ga]MHLL1 uptake was elevated in the infarct relative to the non-infarcted remote myocardium (1.3 ± 0.3 1.0 ± 0.2 %ID/g, p < 0.001) which persisted to 21 d after MI (1.3 ± 0.4 1.1 ± 0.4 %ID/g, p = 0.013). Excess unlabeled compound blocked tracer accumulation in both infarct and non-infarct remote myocardium regions (p < 0.001). Autoradiography and histology confirmed the regional uptake of [Ga]MHLL1 in the infarct and especially border zone regions, as identified by Masson trichrome collagen staining. Immunostaining further delineated persistent FAP expression at 7 d and 21 d post-MI in the border zone, consistent with tracer distribution . The simplified synthesis of [Ga]MHLL1 bears promise for non-invasive characterization of fibroblast activation protein early in remodeling after MI.

Citing Articles

Spatial FAP Expression as Detected by  Ga-FAPI-46 Identifies Myofibroblasts Beyond the Infarct Scar After Reperfusion.

Hess A, Renko A, Schafer A, Jung M, Fraccarollo D, Schmitto J Mol Imaging Biol. 2025; .

PMID: 40029570 DOI: 10.1007/s11307-025-01994-6.


Recent advances in positron emission tomography for detecting early fibrosis after myocardial infarction.

Wu Q, Song J, Liu W, Li L, Li S Front Cardiovasc Med. 2024; 11:1479777.

PMID: 39529975 PMC: 11552091. DOI: 10.3389/fcvm.2024.1479777.


Molecular Imaging of Fibrosis in Benign Diseases: An Overview of the State of the Art.

Zhang Y, Huang W, Jiao H, Song L, Kang L Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543082 PMC: 10974017. DOI: 10.3390/ph17030296.


Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure.

Gehris J, Ervin C, Hawkins C, Womack S, Churillo A, Doyle J Biochem Pharmacol. 2023; 219:115914.

PMID: 37956895 PMC: 10824141. DOI: 10.1016/j.bcp.2023.115914.


Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?.

Neuber S, Ermer M, Emmert M, Nazari-Shafti T Int J Mol Sci. 2023; 24(13).

PMID: 37445658 PMC: 10342089. DOI: 10.3390/ijms241310480.


References
1.
OHanlon R, Grasso A, Roughton M, Moon J, Clark S, Wage R . Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010; 56(11):867-74. DOI: 10.1016/j.jacc.2010.05.010. View

2.
Bektik E, Fu J . Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming. Cells. 2019; 8(7). PMC: 6679082. DOI: 10.3390/cells8070679. View

3.
Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J . Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med. 2018; 59(9):1415-1422. DOI: 10.2967/jnumed.118.210443. View

4.
Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L . Targeting cardiac fibrosis with engineered T cells. Nature. 2019; 573(7774):430-433. PMC: 6752964. DOI: 10.1038/s41586-019-1546-z. View

5.
Zhou Y, Liu S . 64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging. Bioconjug Chem. 2011; 22(8):1459-72. PMC: 3157592. DOI: 10.1021/bc200106p. View